{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:16:28Z","timestamp":1791112588278,"version":"4.1.0"},"reference-count":56,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2009,9,11]],"date-time":"2009-09-11T00:00:00Z","timestamp":1252627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Gabriella Rich Center for Transplantation Biology Research"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Although mesenchymal stromal cells (MSCs) exhibit marked immunoregulatory activity through multiple mechanisms, their potential to completely evade rejection upon transplantation into allogeneic recipients is controversial. To directly address this controversy, the survival of luciferase-labeled MSCs (Luc+ MSCs) was evaluated by imaging in allogeneic recipients. This analysis showed that although MSCs exhibited longer survival compared to fibroblasts (Fib), their survival was significantly shorter compared to that exhibited in syngeneic or in immune-deficient Balb-Nude or non-obese diabetic severe combined immunodeficiency (NOD-SCID) recipients. Graft rejection in re-challenge experiments infusing Luc+ Fib into mice, which had previously rejected Luc+ MSCs, indicated potential induction of immune memory by the MSCs. This was further analyzed in T-cell antigen receptor (TCR) transgeneic mice in which either CD4 TEA mice or CD8 T cells (2C mice) bear a TCR transgene against a specific MHC I or MHC II, respectively. Thus, following a re-challenge with MSCs expressing the cognate MHC haplotype, an enhanced percentage of 2C CD8+ or TEA CD4+ T cells exhibited a memory phenotype (CD122+, CD44+, and CD62Llow). Collectively, these results demonstrate that MSCs are not intrinsically immune-privileged, and under allogeneic settings, these cells induce rejection, which is followed by an immune memory. Considering that the use of allogeneic or even a third party (\u201coff the shelf\u201d) MSCs is commonly advocated for a variety of clinical applications, our results strongly suggest that long-term survival of allogeneic MSCs likely represents a major challenge.<\/jats:p>\n                  <jats:p>Disclosure of potential conflicts of interest is found at the end of this article.<\/jats:p>","DOI":"10.1002\/stem.217","type":"journal-article","created":{"date-parts":[[2009,9,11]],"date-time":"2009-09-11T11:49:18Z","timestamp":1252669758000},"page":"2865-2874","source":"Crossref","is-referenced-by-count":260,"title":["Direct Imaging of Immune Rejection and Memory Induction by Allogeneic Mesenchymal Stromal Cells"],"prefix":"10.1093","volume":"27","author":[{"given":"Lior","family":"Zangi","sequence":"first","affiliation":[{"name":"Department of Immunology, Weizmann Institute of Science, Rehovot, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raanan","family":"Margalit","sequence":"additional","affiliation":[{"name":"Department of Immunology, Weizmann Institute of Science, Rehovot, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomit","family":"Reich-Zeliger","sequence":"additional","affiliation":[{"name":"Department of Immunology, Weizmann Institute of Science, Rehovot, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Bachar-Lustig","sequence":"additional","affiliation":[{"name":"Department of Immunology, Weizmann Institute of Science, Rehovot, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Beilhack","sequence":"additional","affiliation":[{"name":"Department of Medicine and Interdisciplinary Center for Clinical Research (IZKF), W\u00fcrzburg University, W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Negrin","sequence":"additional","affiliation":[{"name":"Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yair","family":"Reisner","sequence":"additional","affiliation":[{"name":"Department of Immunology, Weizmann Institute of Science, Rehovot, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,9,11]]},"reference":[{"key":"2022011222481807100_bib1","first-page":"3","article-title":"[Stromal bone marrow cells and the hematopoietic microenvironment]","volume":"44","author":"Fridenshtein","year":"1982","journal-title":"Arkh Patol"},{"key":"2022011222481807100_bib2","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1681\/ASN.2005020195","article-title":"Isolation and characterization of nontubular sca-1+lin\u2212 multipotent stem\/progenitor cells from adult mouse kidney","volume":"17","author":"Dekel","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"2022011222481807100_bib3","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1182\/blood-2002-06-1830","article-title":"Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates","volume":"101","author":"Devine","year":"2003","journal-title":"Blood"},{"key":"2022011222481807100_bib4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000047856","article-title":"The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion","volume":"169","author":"Gao","year":"2001","journal-title":"Cells Tissues Organs"},{"key":"2022011222481807100_bib5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/01.TP.0000045055.63901.A9","article-title":"Suppression of allogeneic T-cell proliferation by human marrow stromal cells: Implications in transplantation","volume":"75","author":"Tse","year":"2003","journal-title":"Transplantation"},{"key":"2022011222481807100_bib6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1089\/154732804323099190","article-title":"Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells","volume":"13","author":"Zhang","year":"2004","journal-title":"Stem Cells Dev"},{"key":"2022011222481807100_bib7","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","article-title":"Human mesenchymal stem cells modulate allogeneic immune cell responses","volume":"105","author":"Aggarwal","year":"2005","journal-title":"Blood"},{"key":"2022011222481807100_bib8","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1182\/blood-2004-07-2921","article-title":"Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness","volume":"105","author":"Beyth","year":"2005","journal-title":"Blood"},{"key":"2022011222481807100_bib9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.0300-9475.2004.01483.x","article-title":"Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes","volume":"60","author":"Le Blanc","year":"2004","journal-title":"Scand J Immunol"},{"key":"2022011222481807100_bib10","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/jcp.20031","article-title":"Regulation of bone morphogenetic protein-2 expression by endogenous prostaglandin E2 in human mesenchymal stem cells","volume":"200","author":"Arikawa","year":"2004","journal-title":"J Cell Physiol"},{"key":"2022011222481807100_bib11","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1182\/blood-2003-11-3909","article-title":"Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation","volume":"103","author":"Meisel","year":"2004","journal-title":"Blood"},{"key":"2022011222481807100_bib12","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1016\/j.transproceed.2006.10.002","article-title":"Administration of donor-derived mesenchymal stem cells can prolong the survival of rat cardiac allograft","volume":"38","author":"Zhou","year":"2006","journal-title":"Transplant Proc"},{"key":"2022011222481807100_bib13","doi-asserted-by":"crossref","first-page":"8932","DOI":"10.1073\/pnas.132252399","article-title":"Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone","volume":"99","author":"Horwitz","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022011222481807100_bib14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-9255-2-8","article-title":"Mesenchymal stem cells avoid allogeneic rejection","volume":"2","author":"Ryan","year":"2005","journal-title":"J Inflamm (London)"},{"key":"2022011222481807100_bib15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/sj.bmt.1703650","article-title":"Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH)","volume":"30","author":"Ko\u00b8c","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"2022011222481807100_bib16","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.2106\/00004623-200310000-00010","article-title":"Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect","volume":"85-A","author":"Arinzeh","year":"2003","journal-title":"J Bone Joint Surg Am"},{"key":"2022011222481807100_bib17","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/sj.leu.2402786","article-title":"Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe idiopathic aplastic anemia improves stroma","volume":"17","author":"Fouillard","year":"2003","journal-title":"Leukemia"},{"key":"2022011222481807100_bib18","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.bbmt.2004.06.001","article-title":"Replacement of recipient stromal\/mesenchymal cells after bone marrow transplantation using bone fragments and cultured osteoblast-like cells","volume":"10","author":"Cahill","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"2022011222481807100_bib19","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/01.tp.0000214462.63943.14","article-title":"Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease","volume":"81","author":"Ringd\u00e9n","year":"2006","journal-title":"Transplantation"},{"key":"2022011222481807100_bib20","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1038\/sj.leu.2404833","article-title":"Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon","volume":"21","author":"Ringd\u00e9n","year":"2007","journal-title":"Leukemia"},{"key":"2022011222481807100_bib21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2796.2007.01844.x","article-title":"Immunomodulation by mesenchymal stem cells and clinical experience","volume":"262","author":"Le Blanc","year":"2007","journal-title":"J Intern Med"},{"key":"2022011222481807100_bib22","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/6529","article-title":"Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta","volume":"5","author":"Horwitz","year":"1999","journal-title":"Nat Med"},{"key":"2022011222481807100_bib23","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1046\/j.1365-2141.2002.03767.x","article-title":"Treatment of high-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem cells from a related donor with one fully mismatched human leucocyte antigen haplotype","volume":"118","author":"Lee","year":"2002","journal-title":"Br J Haematol"},{"key":"2022011222481807100_bib24","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1182\/blood-2003-04-1193","article-title":"Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals","volume":"102","author":"Djouad","year":"2003","journal-title":"Blood"},{"key":"2022011222481807100_bib25","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1182\/blood-2005-03-1004","article-title":"Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice","volume":"106","author":"Eliopoulos","year":"2005","journal-title":"Blood"},{"key":"2022011222481807100_bib26","doi-asserted-by":"crossref","first-page":"7761","DOI":"10.4049\/jimmunol.176.12.7761","article-title":"Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice","volume":"176","author":"Sudres","year":"2006","journal-title":"J Immunol"},{"key":"2022011222481807100_bib27","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.tp.0000209919.90630.7b","article-title":"Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model","volume":"81","author":"Inoue","year":"2006","journal-title":"Transplantation"},{"key":"2022011222481807100_bib28","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1182\/blood-2005-11-011650","article-title":"Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting","volume":"108","author":"Nauta","year":"2006","journal-title":"Blood"},{"key":"2022011222481807100_bib29","first-page":"29","article-title":"Immunomodulatory effects of mesenchymal stem cells derived from adipose tissues in a rat orthotopic liver transplantation model","volume":"7","author":"Wan","year":"2008","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"2022011222481807100_bib30","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1182\/blood-2007-02-069716","article-title":"Immunomodulatory properties of mesenchymal stromal cells","volume":"110","author":"Nauta","year":"2007","journal-title":"Blood"},{"key":"2022011222481807100_bib31","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3727\/096368908786092793","article-title":"In vivo survival and osteogenic differentiation of allogeneic rat bone marrow mesenchymal stem cells (MSCs)","volume":"17","author":"Kotobuki","year":"2008","journal-title":"Cell Transplant"},{"key":"2022011222481807100_bib32","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1182\/blood-2005-02-0509","article-title":"In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets","volume":"106","author":"Beilhack","year":"2005","journal-title":"Blood"},{"key":"2022011222481807100_bib33","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1046\/j.1365-2141.2003.04669.x","article-title":"Murine marrow-derived mesenchymal stem cell: Isolation, in vitro expansion, and characterization","volume":"123","author":"Meirelles Lda","year":"2003","journal-title":"Br J Haematol"},{"key":"2022011222481807100_bib34","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1089\/ten.2006.12.2343","article-title":"High-yield isolation, expansion, and differentiation of rat bone marrow-derived mesenchymal stem cells with fibrin microbeads","volume":"12","author":"Zangi","year":"2006","journal-title":"Tissue Eng"},{"key":"2022011222481807100_bib35","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.4049\/jimmunol.173.11.6660","article-title":"Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. II. Deletion of effector cells by Fas-Fas ligand apoptosis","volume":"173","author":"Reich-Zeliger","year":"2004","journal-title":"J Immunol"},{"key":"2022011222481807100_bib36","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.exphem.2006.02.017","article-title":"Overcoming T cell-mediated rejection of bone marrow allografts by T-regulatory cells: Synergism with veto cells and rapamycin","volume":"34","author":"Steiner","year":"2006","journal-title":"Exp Hematol"},{"key":"2022011222481807100_bib37","first-page":"2323","article-title":"Ex-vivo acquisition of central memory phenotype is critical for tolerance induction by donor anti-3rd party CD8 T cells in allogeneic bone marrow transplantation","volume":"112","author":"Edelshtein","year":"2008","journal-title":"Blood (ASH Annual Meeting Abstracts) Nov"},{"key":"2022011222481807100_bib38","first-page":"117","article-title":"The immunogenic privilege of corneal allografts","volume":"2","author":"Niederkorn","year":"1989","journal-title":"Reg Immunol"},{"key":"2022011222481807100_bib39","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood.V99.10.3838","article-title":"Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli","volume":"99","author":"Di Nicola","year":"2002","journal-title":"Blood"},{"key":"2022011222481807100_bib40","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1634\/stemcells.21-6-661","article-title":"The profile of gene expression of human marrow mesenchymal stem cells","volume":"21","author":"Silva","year":"2003","journal-title":"Stem Cells"},{"key":"2022011222481807100_bib41","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/(SICI)1097-4652(199603)166:3<585::AID-JCP13>3.0.CO;2-6","article-title":"Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: Effects of dexamethasone and IL-1 alpha","volume":"166","author":"Haynesworth","year":"1996","journal-title":"J Cell Physiol"},{"key":"2022011222481807100_bib42","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/01.TP.0000082540.43730.80","article-title":"Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells","volume":"76","author":"Rasmusson","year":"2003","journal-title":"Transplantation"},{"key":"2022011222481807100_bib43","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1365-2249.2007.03422.x","article-title":"Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells","volume":"149","author":"Ryan","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"2022011222481807100_bib44","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/01.tp.0000203137.06587.4a","article-title":"\u201cFirefly rats\u201d as an organ\/cellular source for long-term in vivo bioluminescent imaging","volume":"81","author":"Hakamata","year":"2006","journal-title":"Transplantation"},{"key":"2022011222481807100_bib45","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1634\/stemcells.2007-0790","article-title":"Bone marrow-derived mesenchymal stem cells ameliorate autoimmune enteropathy independently of regulatory T cells","volume":"26","author":"Parekkadan","year":"2008","journal-title":"Stem Cells"},{"key":"2022011222481807100_bib46","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood-2005-04-1496","article-title":"Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy","volume":"106","author":"Zappia","year":"2005","journal-title":"Blood"},{"key":"2022011222481807100_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0039.2006.00739.x","article-title":"Immune regulation by mesenchymal stem cells: Two sides to the coin","volume":"69","author":"Stagg","year":"2007","journal-title":"Tissue Antigens"},{"key":"2022011222481807100_bib48","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1182\/blood-2005-07-2793","article-title":"Interferon-gamma-stimulated marrow stromal cells: A new type of nonhematopoietic antigen-presenting cell","volume":"107","author":"Stagg","year":"2006","journal-title":"Blood"},{"key":"2022011222481807100_bib49","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1182\/blood-2007-03-078774","article-title":"Immunogenicity of umbilical cord tissue derived cells","volume":"111","author":"Cho","year":"2008","journal-title":"Blood"},{"key":"2022011222481807100_bib50","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1182\/blood-2006-01-0057","article-title":"Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma","volume":"107","author":"Chan","year":"2006","journal-title":"Blood"},{"key":"2022011222481807100_bib51","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.4049\/jimmunol.176.5.2864","article-title":"The immunogenicity and immunomodulatory function of osteogenic cells differentiated from mesenchymal stem cells","volume":"176","author":"Liu","year":"2006","journal-title":"J Immunol"},{"key":"2022011222481807100_bib52","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/153537020623100105","article-title":"Mesenchymal stem cells and the treatment of cardiac disease","volume":"231","author":"Minguell","year":"2006","journal-title":"Exp Biol Med (Maywood)"},{"key":"2022011222481807100_bib53","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet"},{"key":"2022011222481807100_bib54","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","article-title":"Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells","volume":"363","author":"Le Blanc","year":"2004","journal-title":"Lancet"},{"issue":"Suppl 2","key":"2022011222481807100_bib55","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2036.2007.03478.x","article-title":"Review article: Stem cell transplantation for the treatment of gastrointestinal diseases\u2013current applications and future perspectives","volume":"26","author":"Al-Toma","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"2022011222481807100_bib56","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/ar2128","article-title":"Cell therapy for autoimmune diseases","volume":"9","author":"Dazzi","year":"2007","journal-title":"Arthritis Res Ther"}],"container-title":["Stem Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fstem.217","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/stem.217","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/stem.217","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/stmcls\/article-pdf\/27\/11\/2865\/41949483\/stmcls_27_11_2865.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stmcls\/article-pdf\/27\/11\/2865\/41949483\/stmcls_27_11_2865.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T21:56:35Z","timestamp":1642542995000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stmcls\/article\/27\/11\/2865-2874\/6401852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,11]]},"references-count":56,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2009,9,11]]},"published-print":{"date-parts":[[2009,11,1]]}},"URL":"https:\/\/doi.org\/10.1002\/stem.217","relation":{},"ISSN":["1066-5099","1549-4918"],"issn-type":[{"value":"1066-5099","type":"print"},{"value":"1549-4918","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2009,11,1]]},"published":{"date-parts":[[2009,9,11]]}}}